Accula SARS-CoV-2
Performed on the Accula Dock is a molecular in vitro diagnostic test utilizing PCR and lateral flow technologies for the qualitative, visual detection of nucleic acid from SARS-CoV-2 in clinician-collected nasal or nasal mid-turbinate swab specimens or clinician-instructed self-collected (collected on site) nasal swab specimens, collected from individuals suspected of COVID-19 by their healthcare provider.
Rapid testing results—RT-PCR SARS-CoV-2 results in ~30 minutes
Streamlined process—CLIA-waived workflow
Simplified sample collection—nasal swabs and nasal mid-turbinate swabs
Easy—store at room temperature, no need for refrigeration
Accurate results— Positive percent agreement (PPA) 95.8% to 100% and negative percent agreement 100% in prospective and retrospective clinical studies.
$50 per unit
Contact me for bulk pricing
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum. Read DealStream's Terms Of Use before responding to any listing. Learn how to stay safe in our marketplace.
Request Information
Want to learn more about this listing? Log in now. New to DealStream? Discover how artificial intelligence can help you find better deals! Sign up for a Free Account today and get your first Search Genius deal tomorrow.
Sign UpDealStream Awards & Reviews
